Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan
· Delayed Price · Currency is TWD 71.30
-4.30 (-5.69%)
May 23, 2025, 1:30 PM CST
TPE:6657 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -285.26 | -231.08 | -260.38 | -265.66 | -120.24 | -129.48 | Upgrade
|
| Depreciation & Amortization | 22.6 | 22.76 | 23.78 | 24.35 | 22.85 | 19.8 | Upgrade
|
| Other Amortization | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.22 | - | - | - | Upgrade
|
| Stock-Based Compensation | 16.33 | 14.85 | 14.87 | 11.09 | 4.92 | 6.9 | Upgrade
|
| Other Operating Activities | -0.87 | -0.72 | -1.04 | -0.01 | 0.46 | 0.07 | Upgrade
|
| Change in Accounts Receivable | 0.6 | 0.08 | 0.61 | -0.79 | 0.31 | -0.3 | Upgrade
|
| Change in Inventory | -0.16 | 0.04 | -0.15 | 0.16 | -0.02 | 0.04 | Upgrade
|
| Change in Accounts Payable | 0.12 | -0.03 | -0.03 | 0.07 | 0.02 | 0.07 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | -0.04 | -0.15 | Upgrade
|
| Change in Other Net Operating Assets | 10.86 | 13.35 | -2.97 | -2.12 | -5.6 | 3.97 | Upgrade
|
| Operating Cash Flow | -235.77 | -180.71 | -225.05 | -232.84 | -97.29 | -98.92 | Upgrade
|
| Capital Expenditures | -0.78 | -0.75 | -0.84 | -6.45 | -8.9 | -4.63 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.14 | - | - | Upgrade
|
| Investment in Securities | -198 | 192.11 | -58.11 | 182 | -107 | 64 | Upgrade
|
| Other Investing Activities | 0.07 | 1.87 | - | 0 | 0.13 | 0.07 | Upgrade
|
| Investing Cash Flow | -198.71 | 193.23 | -58.96 | 175.42 | -115.76 | 59.44 | Upgrade
|
| Long-Term Debt Repaid | - | -6.2 | -6.52 | -6.51 | -6.79 | -4.23 | Upgrade
|
| Net Debt Issued (Repaid) | -6.13 | -6.2 | -6.52 | -6.51 | -6.79 | -4.23 | Upgrade
|
| Issuance of Common Stock | 576.39 | 151.49 | 446.94 | 4.75 | 294.65 | 9 | Upgrade
|
| Other Financing Activities | - | - | - | - | 0.13 | - | Upgrade
|
| Financing Cash Flow | 570.26 | 145.29 | 440.42 | -1.75 | 287.98 | 4.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.15 | 0.09 | - | - | - | - | Upgrade
|
| Net Cash Flow | 135.92 | 157.9 | 156.41 | -59.18 | 74.94 | -34.71 | Upgrade
|
| Free Cash Flow | -236.55 | -181.47 | -225.89 | -239.29 | -106.18 | -103.55 | Upgrade
|
| Free Cash Flow Margin | -3131.47% | -2341.79% | -3155.81% | -3255.16% | -1417.84% | -1462.36% | Upgrade
|
| Free Cash Flow Per Share | -2.99 | -2.38 | -3.14 | -3.59 | -1.77 | -1.75 | Upgrade
|
| Cash Interest Paid | 0.25 | 0.21 | 0.21 | 0.21 | 0.28 | 0.35 | Upgrade
|
| Cash Income Tax Paid | 0.8 | 0.85 | 0.53 | -0.09 | -0.06 | 0.2 | Upgrade
|
| Levered Free Cash Flow | -139.92 | -110.26 | -129.83 | -148.4 | -57.24 | -52.03 | Upgrade
|
| Unlevered Free Cash Flow | -139.76 | -110.13 | -129.69 | -148.27 | -57.06 | -51.81 | Upgrade
|
| Change in Net Working Capital | -10.25 | -12.45 | 3.9 | 7.4 | -0.33 | -9.44 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.